| 1 |
33524314 | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. | 2021 Jun |
1 |
| 2 |
33880839 | Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study. | 2021 Aug |
2 |
| 3 |
25075941 | The Use of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase. | 2014 Sep |
1 |
| 4 |
22544804 | Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B. | 2012 Dec |
1 |
| 5 |
20600036 | Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. | 2010 Oct |
1 |
| 6 |
21086562 | Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients. | 2010 Nov 21 |
1 |